Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

February 21, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search